Analyses / NKE
Near 52-week lows at 17x earnings, but revenue and EPS are shrinking. Data gaps limit conviction.
A free account reveals NKE's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
If the turnaround stabilizes sales, the stock may re-rate from its low P/E (17.3x trailing, 17.3x forward). Price sits about 12% above its 52-week low of $31.97 and 45% below the high of $69.14, so a recovery could be sharp. Insider share flow was net positive in the provider data (28.7M shares bought vs 22.3M sold). Current ratio of 1.96 suggests near-term liquidity is adequate. Dividend yield is 1.37%.
▼ Bear Case
Revenue growth is -3.24% and EPS growth is -13.39% (5-year EPS growth -10.02%), so the cheap multiple may reflect falling earnings. Recent headlines describe the investor day outlook as disappointing. Payout ratio of 77.45% leaves limited room for dividend growth if earnings keep falling. Net margin of 6.7% and operating margin of 8.18% are thin. Price-to-book of 4.58x is high relative to tangible book of $9.86 per share.
Valuation
Cheap on earnings, weak on growth — score 55/100
Low trailing and forward P/E against falling EPS. Price-to-book is high versus tangible book, so asset backing is thin.
Technical Levels
Support · $34.96 (Intraday day low) · $31.97 (52-week low)
Resistance · $36.88 (Intraday day high) · $40.00 (Target level (analyst scenario, not a provider level))
RSI: RSI not available in payload
Financial Health
Score 60/100. Liquidity ratios are adequate. Leverage and interest coverage are not in the payload, so the balance sheet read is incomplete.
Catalysts
| Investor day outlook follow-up and any revised guidance | Next earnings report (date not in payload) | high |
| Whether revenue decline rate narrows | Next two quarterly reports | high |
| Dividend coverage as payout ratio stays near 77% | Next dividend declaration | medium |
Risk Flags
See NKE's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock NKE free →Recent News
- Nike is Riding the GTA 6 Hype. Will Its Stock Price See Any Relief?Yahoo
- Sporticast: Nike’s Outlook Disappoints Investors AgainYahoo
- Nike: The Investor Day Event Does Not Change My Bearish StanceSeekingAlpha
- NIKE Investor Day Update: It's Gonna Get Worse Before It Gets BetterSeekingAlpha
- 3 Dividend Stocks To Watch In November 2026Yahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full NKE analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
NKE FAQ
Is NKE a buy right now?
NIKE, Inc.'s current read is a Recovery watch (value with negative growth) setup with low confidence over a 3-6 months horizon. Valuation: Cheap on earnings, weak on growth. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is NKE overvalued?
Cheap on earnings, weak on growth (valuation score 55/100). Low trailing and forward P/E against falling EPS. Price-to-book is high versus tangible book, so asset backing is thin.
What are the risks of buying NKE?
Revenue growth is -3.24% and EPS growth is -13.39% (5-year EPS growth -10.02%), so the cheap multiple may reflect falling earnings. Recent headlines describe the investor day outlook as disappointing. Payout ratio of 77.45% leaves limited room for dividend growth if earnings keep falling. Net margin of 6.7% and operating margin of 8.18% are thin. Price-to-book of 4.58x is high relative to tangible book of $9.86 per share.